Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 191.79
-7.21 (-3.62%)
Jul 21, 2025, 3:00 PM CST
Beijing Hotgen Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Operating Revenue | 482.12 | 505.01 | 544.62 | 3,532 | 5,307 | 511.67 | Upgrade |
Other Revenue | 5.89 | 5.89 | 3.22 | 24.41 | 62.65 | 1.86 | Upgrade |
| 488.02 | 510.9 | 547.84 | 3,557 | 5,369 | 513.53 | Upgrade | |
Revenue Growth (YoY) | 5.85% | -6.74% | -84.60% | -33.76% | 945.54% | 144.06% | Upgrade |
Cost of Revenue | 258.78 | 257.18 | 211.72 | 1,766 | 2,254 | 189.95 | Upgrade |
Gross Profit | 229.24 | 253.72 | 336.11 | 1,790 | 3,116 | 323.59 | Upgrade |
Selling, General & Admin | 296.74 | 289.77 | 258.6 | 483.58 | 404.26 | 161.44 | Upgrade |
Research & Development | 111.07 | 113.31 | 132.88 | 191.14 | 131.92 | 47.61 | Upgrade |
Other Operating Expenses | 2.48 | 3.45 | 3.58 | 9.2 | 5.04 | 0.88 | Upgrade |
Operating Expenses | 411.65 | 407.9 | 381.66 | 695.26 | 541.92 | 211.13 | Upgrade |
Operating Income | -182.41 | -154.18 | -45.55 | 1,095 | 2,574 | 112.46 | Upgrade |
Interest Expense | -0.45 | -0.45 | -1.01 | -2.32 | -1.27 | -0.45 | Upgrade |
Interest & Investment Income | 66.05 | 32.85 | 39.59 | 34.52 | 34.26 | 8.42 | Upgrade |
Currency Exchange Gain (Loss) | -0.78 | -0.78 | 4.31 | 4.95 | -14.64 | 1.7 | Upgrade |
Other Non Operating Income (Expenses) | 0.66 | 0.24 | -1.27 | 3.31 | -4.82 | -0 | Upgrade |
EBT Excluding Unusual Items | -116.94 | -122.32 | -3.92 | 1,135 | 2,587 | 122.12 | Upgrade |
Gain (Loss) on Sale of Investments | -42.1 | -9.36 | -23.68 | 7.52 | 3.12 | - | Upgrade |
Gain (Loss) on Sale of Assets | -3.39 | -1.63 | -0.64 | -0.34 | -14.21 | -0.18 | Upgrade |
Asset Writedown | -60.87 | -60.85 | -41.79 | -70.06 | -8.51 | -0.14 | Upgrade |
Other Unusual Items | 6.21 | 6.29 | 85.02 | 2.63 | 14.22 | 5.62 | Upgrade |
Pretax Income | -217.09 | -187.87 | 14.99 | 1,075 | 2,582 | 127.42 | Upgrade |
Income Tax Expense | 6.95 | 8.06 | -1.73 | 150.1 | 379.44 | 16.13 | Upgrade |
Earnings From Continuing Operations | -224.04 | -195.94 | 16.71 | 925.12 | 2,202 | 111.3 | Upgrade |
Minority Interest in Earnings | 3.97 | 4.93 | 12.21 | 19.62 | -16.61 | 0.77 | Upgrade |
Net Income | -220.07 | -191 | 28.92 | 944.74 | 2,186 | 112.07 | Upgrade |
Net Income to Common | -220.07 | -191 | 28.92 | 944.74 | 2,186 | 112.07 | Upgrade |
Net Income Growth | - | - | -96.94% | -56.78% | 1850.41% | 230.80% | Upgrade |
Shares Outstanding (Basic) | 94 | 92 | 88 | 91 | 92 | 92 | Upgrade |
Shares Outstanding (Diluted) | 94 | 92 | 88 | 92 | 92 | 92 | Upgrade |
Shares Change (YoY) | 8.41% | 4.59% | -3.88% | -0.14% | -0.12% | 23.13% | Upgrade |
EPS (Basic) | -2.33 | -2.07 | 0.33 | 10.33 | 23.75 | 1.22 | Upgrade |
EPS (Diluted) | -2.33 | -2.07 | 0.33 | 10.28 | 23.75 | 1.22 | Upgrade |
EPS Growth | - | - | -96.81% | -56.72% | 1852.80% | 168.66% | Upgrade |
Free Cash Flow | -47.5 | -88.57 | -461.9 | 413.54 | 2,246 | -7.65 | Upgrade |
Free Cash Flow Per Share | -0.50 | -0.96 | -5.23 | 4.50 | 24.40 | -0.08 | Upgrade |
Dividend Per Share | - | - | 0.200 | - | 3.378 | 1.014 | Upgrade |
Dividend Growth | - | - | - | - | 233.34% | 400.00% | Upgrade |
Gross Margin | 46.97% | 49.66% | 61.35% | 50.34% | 58.03% | 63.01% | Upgrade |
Operating Margin | -37.38% | -30.18% | -8.31% | 30.79% | 47.93% | 21.90% | Upgrade |
Profit Margin | -45.09% | -37.39% | 5.28% | 26.56% | 40.71% | 21.82% | Upgrade |
Free Cash Flow Margin | -9.73% | -17.34% | -84.31% | 11.63% | 41.82% | -1.49% | Upgrade |
EBITDA | -92.3 | -69.84 | 15.66 | 1,184 | 2,631 | 141.61 | Upgrade |
EBITDA Margin | -18.91% | -13.67% | 2.86% | 33.30% | 49.00% | 27.57% | Upgrade |
D&A For EBITDA | 90.11 | 84.33 | 61.2 | 89.39 | 57.5 | 29.15 | Upgrade |
EBIT | -182.41 | -154.18 | -45.55 | 1,095 | 2,574 | 112.46 | Upgrade |
EBIT Margin | -37.38% | -30.18% | -8.31% | 30.79% | 47.93% | 21.90% | Upgrade |
Effective Tax Rate | - | - | - | 13.96% | 14.70% | 12.66% | Upgrade |
Revenue as Reported | 488.02 | 510.9 | 547.84 | 3,557 | 5,369 | 513.53 | Upgrade |
Advertising Expenses | - | 15.59 | 13.38 | 55.08 | 68.41 | 7.17 | Upgrade |
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.